Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

Y-mAbs Therapeutics (YMAB) announced the publication of interim data from a Phase 2 clinical trial evaluating naxitamab with ...

Nature Communications is a bimonthly peer-reviewed scientific journal published by the Nature Publishing Group since 2010. The editor in chief is Lesley Anson. It is multidisciplinary in scope, with ...

Neuroblastoma is a solid tumor that occurs in children. When high-risk, the disease has a poor prognosis. Decades ago, adding ...

Innovative electronic textiles with integrated magnetoresistive sensors offer touchless control, revolutionizing wearables ...

A company’s internal communication strategy is the foundation of such connection and a crucial contributor to employee ...

Liver fibrosis develops from excessive matrix produced by activated hepatic stellate cells (HSCs). Here, authors identify ABHD17B via an siRNA screen and show that ABHD17B regulates the fibrotic ...

Innovative urea-powered nanomotors show promise in bladder cancer treatment, improving immune activation and tumor growth ...

Discover the beauty of organic logos and their impact on your business. Explore the top 10 designs of 2024 and harness the power of nature today. Have you ever stopped to appreciate the intricate ...

Large parts of the surface of Mars are colored red. New findings about the origin of the color provide an insight into the ...

A satellite company owned by Elon Musk is on a possible fast track to take over a large federal contract to modernize the ...

Information about how we partner with researchers from across the globe to bring their most significant discoveries to the widest possible audience.